SCHEMBL8259803

SCHEMBL8259803

CCc1nc(N)nc(N)c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HEXA P06865 8/20 0.52
HEXB P07686 8/20 0.52
DHFR P00374 7/20 0.48
MEN1 O00255 1/20 0.46
SLC22A1 O15245 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
HTR2A P28223 1/20 0.46
ADRA1A P35348 1/20 0.46
HTR2B P41595 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KMT2A Q03164 1/20 0.46
PDE4D Q08499 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15508426 0.81 TLR8 (0.44) HEXAHEXBDHFRMEN1SLC22A1
SCHEMBL11497860 0.79 GAA (0.36) HEXAHEXBDHFRMEN1SLC22A1
SCHEMBL19242058 0.77 HEXA (0.47) HEXAHEXBDHFRMEN1SLC22A1
SCHEMBL12484463 0.76 HEXA (0.48) HEXAHEXBDHFRMEN1SLC22A1
SCHEMBL4147996 0.76 HEXA (0.48) HEXAHEXBDHFRMEN1SLC22A1
SCHEMBL10049719 0.76 LMNA (0.39) ALDH1A1LMNA
SCHEMBL20503385 0.74 HEXA (0.47) HEXAHEXBDHFRMEN1SLC22A1
SCHEMBL6358662 0.74 HEXA (0.47) HEXAHEXBDHFRMEN1SLC22A1
SCHEMBL3267542 0.74 HEXA (0.47) HEXAHEXBDHFRMEN1SLC22A1
SCHEMBL15434706 0.74 TLR8 (0.40) HEXAHEXBDHFRMEN1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017052479-A1 2,4-DIAMINO-6-ETHYLPYRIMIDINE DERIVATIVES WITH ANTIMALARIAL ACTIVITIES AGAINST PLASMODIUM FALCIPARUM NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY (TH) 2017-03-30 WO disclosed
WO-2006096405-A2 TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS WITH PYRIMETHAMINE AND ANALOGUES ALSGEN, INC. (US) 2006-09-14 WO disclosed